Cancer patients, pharmaceutical companies, and clinical trial contract research organizations (CROs).

The Center for Precision Medicine of Chi Mei Hospital integrates expertise in pathology and precision medicine to establish a service platform covering the entire process from cancer genetic testing consultation clinics to testing and result interpretation. It also builds a comprehensive ecosystem encompassing assay development, validation, collaboration in clinical trials, and the real-world implementation. The genetic testing consultation clinic is led by pathologists with expertise in pathological diagnosis, targeted therapies, genetic testing, and cancer genetics, providing a complete workflow that includes test explanation, pathology review, specimen assessment, report issuance, and interpretation of genetic reports. 

Through various molecular testing technologies, the team maximizes specimen usability, overcomes multiple barriers faced by cancer patients in accessing genetic testing, and comprehensively enhances the accessibility, usability, and clinical utilities of genetic testing. The core laboratory also collaborates with pharmaceutical companies and CROs to hasten the translation from assay development  to clinical application and to comprehensively optimize patient enrollment in cancer clinical trials.

• R&D capabilities which can be well integrated with early-phase clinical trials and establish a comprehensive ecosystem spanning assay development, validation, collaboration in case screening and real-world implementation of testing.
• A multidisciplinary team that emphasizes knowledge, technology, quality, and communication, ensuring professional and comprehensive cancer molecular diagnostic services.
• Tailoring optimized testing workflows and assays for different cancer types and specimen conditions, making the test possible in each patient specimen.
• By integrating the above strengths, establish a cancer genetic testing consultation clinic that delivers comprehensive services ranging from test explanation, pathology review, specimen assessment, and report issuance to genetic report interpretation.